Holen Sie sich die Stockscreener-App
153.23
1.71%
-1.90
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
| Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-09-09 | $155.6 | $152.4 | $3.17 | 290,784.0 | -1.33% |
| 2026-09-08 | $156.8 | $151.8 | $5.05 | 818,660.0 | -0.33% |
| 2026-09-04 | $159.8 | $154.8 | $4.97 | 926,004.0 | -1.71% |
| 2026-09-03 | $159.9 | $156.8 | $3.17 | 678,497.0 | +0.35% |
| 2026-09-02 | $160.4 | $155.1 | $5.34 | 1,037,847.0 | +0.66% |
| 2026-09-01 | $157.0 | $153.7 | $3.33 | 878,419.0 | +1.77% |
| 2026-08-31 | $155.0 | $151.8 | $3.23 | 1,743,219.0 | -0.02% |
| 2026-08-28 | $156.6 | $153.1 | $3.49 | 812,952.0 | -1.19% |
| 2026-08-27 | $156.8 | $154.6 | $2.14 | 730,267.0 | -0.43% |
| 2026-08-26 | $159.4 | $152.0 | $7.38 | 1,119,039.0 | +2.10% |
| 2026-08-25 | $156.1 | $152.0 | $4.12 | 1,041,779.0 | +0.22% |
| 2026-08-24 | $154.6 | $151.8 | $2.79 | 1,177,268.0 | +0.31% |
| 2026-08-21 | $155.3 | $152.5 | $2.75 | 1,227,586.0 | -0.24% |
| 2026-08-20 | $155.8 | $152.5 | $3.31 | 870,633.0 | -1.68% |
| 2026-08-19 | $156.6 | $154.3 | $2.22 | 1,162,806.0 | +0.85% |
| 2026-08-18 | $156.2 | $153.5 | $2.78 | 1,037,481.0 | -0.17% |
| 2026-08-17 | $154.8 | $150.7 | $4.12 | 1,168,944.0 | +1.16% |
| 2026-08-14 | $153.4 | $148.8 | $4.64 | 1,305,092.0 | +1.26% |
| 2026-08-13 | $155.8 | $150.2 | $5.61 | 2,055,521.0 | -3.62% |
| 2026-08-12 | $160.0 | $154.9 | $5.12 | 2,093,606.0 | -3.37% |
| 2026-08-11 | $165.5 | $161.8 | $3.68 | 808,042.0 | -1.81% |
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Neurocrine Biosciences Inc-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der NBIX-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Neurocrine Biosciences Inc-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf 2026
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-09 | $160.4 | $151.8 | $8.66 | 4,630,211.0 | -0.63% |
| 2026-08 | $170.9 | $148.8 | $22.10 | 25,622,075.0 | -7.66% |
| 2026-07 | $186.1 | $164.6 | $21.56 | 28,746,865.0 | -1.03% |
| 2026-06 | $171.5 | $154.1 | $17.44 | 25,894,268.0 | +6.47% |
| 2026-05 | $162.4 | $129.9 | $32.53 | 25,750,269.0 | +20.22% |
| 2026-04 | $134.2 | $125.3 | $8.89 | 24,690,613.0 | -0.05% |
| 2026-03 | $134.8 | $125.1 | $9.72 | 21,803,616.0 | -0.39% |
| 2026-02 | $142.8 | $122.1 | $20.68 | 25,235,645.0 | -2.80% |
| 2026-01 | $142.2 | $129.2 | $12.98 | 22,239,286.0 | -4.07% |
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf 2025
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-12 | $160.2 | $140.6 | $19.62 | 19,762,746.0 | -7.37% |
| 2025-11 | $157.7 | $137.0 | $20.65 | 20,892,870.0 | +6.25% |
| 2025-10 | $150.0 | $133.6 | $16.37 | 21,451,304.0 | +2.02% |
| 2025-09 | $148.0 | $135.6 | $12.39 | 18,410,355.0 | +0.56% |
| 2025-08 | $140.0 | $123.7 | $16.36 | 17,391,920.0 | +8.87% |
| 2025-07 | $137.4 | $126.2 | $11.29 | 20,229,382.0 | +2.02% |
| 2025-06 | $128.7 | $121.8 | $6.83 | 17,509,187.0 | +2.17% |
| 2025-05 | $130.5 | $105.5 | $25.01 | 32,865,785.0 | +14.24% |
| 2025-04 | $110.9 | $84.23 | $26.66 | 37,381,813.0 | -2.63% |
| 2025-03 | $119.0 | $105.2 | $13.83 | 24,178,404.0 | -6.84% |
| 2025-02 | $153.9 | $113.0 | $40.88 | 31,873,185.0 | -21.80% |
| 2025-01 | $154.6 | $136.1 | $18.48 | 18,531,081.0 | +11.22% |
Neurocrine Biosciences Inc-Aktien (NBIX) Preisverlauf 2024
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2024-12 | $140.0 | $125.2 | $14.79 | 18,782,921.0 | +8.13% |
| 2024-11 | $129.7 | $115.3 | $14.40 | 19,906,873.0 | +5.39% |
| 2024-10 | $131.3 | $111.0 | $20.30 | 19,443,578.0 | +4.38% |
| 2024-09 | $128.8 | $114.1 | $14.73 | 19,963,392.0 | -9.32% |
| 2024-08 | $158.0 | $119.8 | $38.22 | 21,829,501.0 | -10.25% |
| 2024-07 | $150.4 | $135.8 | $14.54 | 15,345,591.0 | +2.83% |
| 2024-06 | $141.5 | $129.3 | $12.16 | 16,164,088.0 | +1.67% |
| 2024-05 | $145.8 | $131.9 | $13.88 | 16,706,330.0 | -1.55% |
| 2024-04 | $145.0 | $130.1 | $14.87 | 16,621,593.0 | -0.28% |
| 2024-03 | $148.4 | $129.2 | $19.22 | 19,907,081.0 | +5.77% |
| 2024-02 | $143.2 | $128.0 | $15.16 | 18,185,535.0 | -6.70% |
| 2024-01 | $143.3 | $129.5 | $13.85 | 15,057,095.0 | +6.08% |
0.66%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):